HealthDay - TUESDAY, March 16 (HealthDay News) -- A simple genetic test that helps
doctors delimitate the best dose of the blood-thinner drug warfarin for
individual career could reduce hospitalizations by one-third during the
early dose-adjustment phase, a new study has found.

More: - Read the rest here